Quick Comparison
| Reishi | Tianeptine | |
|---|---|---|
| Half-Life | Bioactive compounds accumulate with daily use | 2.5-3 hours (tianeptine), 7-8 hours (active metabolite MC5) |
| Typical Dosage | Standard: 1000-3000 mg daily of extract. Dual-extract (water + alcohol extraction) preferred to capture both polysaccharides and triterpenes. Take in the evening due to calming effects. Spore oil: 500-1000 mg daily. Effects build over 2-4 weeks. | Prescription dose: 12.5 mg three times daily (Stablon). Extended-release: 25 mg once daily (Tianeurax). Do not exceed prescribed doses — abuse potential at higher doses due to opioid activity. |
| Administration | Oral (capsules, powder, tincture, tea). Dual-extract preferred. Bitter taste in powder/tea form. | Oral (tablets). Immediate-release (12.5 mg TID) or extended-release (25 mg QD). |
| Research Papers | 8 papers | 10 papers |
| Categories |
Mechanism of Action
Reishi
Reishi's triterpenes (ganoderic acids A, C, D, H; ganoderenic acids) modulate the HPA axis by reducing CRH and ACTH release, lowering cortisol via glucocorticoid receptor feedback. Ganoderic acids have direct sedative effects through GABA-A receptor modulation (possibly allosteric at the benzodiazepine site) and 5-HT2A/2C serotonergic modulation. Beta-(1,3)-(1,6)-glucan polysaccharides bind Dectin-1 and complement receptor 3 (CR3) on macrophages, natural killer cells, and dendritic cells, activating NF-kB and MAPK signaling for immune modulation. Reishi inhibits histamine release from mast cells via Fc epsilon RI downregulation and stabilizes mast cell membranes (anti-allergic effect). Antioxidant properties involve upregulation of superoxide dismutase (SOD1/SOD2), catalase, and glutathione peroxidase. Ganoderic acids may also inhibit 5-alpha-reductase and ACE.
Tianeptine
Tianeptine is a full agonist at mu-opioid (MOR) and delta-opioid (DOR) receptors, mediating both its antidepressant/anxiolytic effects and abuse potential at high doses. Paradoxically, it enhances serotonin reuptake via SERT—opposite to SSRIs—yet still produces antidepressant effects, possibly through opioid-mediated mood regulation. Tianeptine modulates glutamatergic signaling by reversing stress-induced downregulation of AMPA receptor subunits (GluA1/GluA2) and restoring synaptic plasticity. In the hippocampus and amygdala, it prevents stress-induced dendritic atrophy, spine loss, and CA3 pyramidal cell damage—likely through opioid receptor activation and downstream HPA axis effects. It increases BDNF levels and promotes neurogenesis. The combination of opioid agonism, glutamate normalization, and neuroplasticity enhancement underlies its unique profile.
Risks & Safety
Reishi
Common
Digestive discomfort, dry mouth, dizziness.
Serious
Rare hepatotoxicity reported — avoid with liver disease. May interact with blood thinners and immunosuppressants.
Rare
Allergic reaction, nosebleeds.
Tianeptine
Common
Nausea, constipation, abdominal pain, headache, dizziness, dry mouth.
Serious
Opioid-like effects at high doses (euphoria, dependence, respiratory depression). Withdrawal syndrome with abrupt cessation after chronic high-dose use. Abuse and overdose deaths reported.
Rare
Hepatotoxicity, skin reactions.
Full Profiles
Reishi →
Known as the 'mushroom of immortality' in Chinese medicine, Reishi (Ganoderma lucidum) is an adaptogenic mushroom primarily used for stress reduction, immune support, and sleep improvement. Unlike the stimulating effects of Cordyceps or Lion's Mane, Reishi is calming and is best taken in the evening. Its triterpene compounds modulate the HPA axis and support GABAergic relaxation.
Tianeptine →
An atypical antidepressant with unique nootropic properties. Unlike SSRIs which increase serotonin, tianeptine is a mu-opioid receptor agonist and enhances serotonin reuptake. It reduces stress-induced neuronal damage in the hippocampus and amygdala, improving mood, cognition, and stress resilience simultaneously. Prescription medication in many countries but carries abuse potential at high doses.